Company Legal Name
Latest Valuation
Founded Year
Headquarter
Loyal Health Inc. is a San Francisco-based biotech company developing pharmaceutical interventions to extend the lifespan and healthspan of dogs. Founded in 2019, the company represents a pioneering approach to companion animal longevity, addressing the significant market opportunity in pet healthcare where owners increasingly seek advanced medical solutions for their animals. Loyal's research focuses on developing FDA-approved drugs specifically designed to target aging mechanisms in canines, potentially revolutionizing veterinary medicine. The company operates at the intersection of longevity science and veterinary therapeutics, positioning itself as a first-mover in the emerging field of companion animal anti-aging treatments and lifespan extension.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





